Biotech company developing the first autologous iPSC-derived neuron replacement cell therapy for Parkinson's disease using stem cell biology and advanced genomics.
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account